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Abstract. In this vision paper we envisage paradigmatic change transforming the 
health professional from the empowered agent of a dependent patient into the final 
decision supporter of an empowered person; a person who comes equipped with the 
preliminary opinion of an apomediative personalised decision support tool and the 
enhanced health decision literacy it produces. The anomalies in the current paradigm 
that will produce this change arise from unworkable attempts to combine multi-
criterial personal preferences and the best available evidence in a medical reasoning 
model. Multi-Criteria Decision Analysis (MCDA)-based decision support tools 
provide one mechanism for achieving this synthesis in a transparent way in a specific 
case whilst, simultaneously, increasing the generic health decision literacy and 
competencies of both person and clinician. The educational task for both is less than 
might be expected because of their familiarity, as consumers, with the many 
comparison websites and magazines for products and services using an informal 
version of MCDA. The educational task, particularly for the clinician, is primarily 
one of acknowledging that MCDA is a decision competence that has the potential, 
not only to enhance decision quality, but also facilitate communication between 
person and professional, who will now be talking the same decisional language. 
Experience from developing the MyBoneHealth tool confirms both the feasibility 
and challenges of delivering a MCDA-based decision support and educational tool.  
Keywords. Multi-Criteria Decision Analysis, decision support, health decision 
literacy, preferences 
1. The Vision 
The anomalies in the current paradigm of medical practice are now so extensive that the 
switch to the paradigm-in-waiting is imminent. These anomalies are not the bad practices 
that some inside medicine are attempting to address, within the existing paradigm, by 
attacking ‘too much medicine’ and ‘overdiagnosis and treatment’, and promoting 
‘minimally disruptive medicine’ and ‘kind and caring medicine’. Much-needed and 
valuable progress on these aspects of bad practice can, and should indeed, be made 
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without paradigm change. But the key anomaly requires fundamental change that cannot 
be absorbed and accommodated while the medical hegemony over health and healthcare 
remains intact. The required hegemonic change will transform health professionals from 
being the empowered agent of the dependent patient into the decision supporter of the 
empowered person; the person coming equipped with the preliminary opinion of an 
apomediative personalised decision support tool and the health decision literacy it brings.  
The anomalies that will tip the paradigm arise in the increasingly strained attempts 
to introduce the person’s preferences into the existing medical decision making process 
– an introduction now accepted as ethically and legally mandated. The conventional 
model of clinical decision making, lacks an analytical place for the preferences of the 
person for whom multiple considerations, as well as their disease, matter. These 
preferences can only be somehow ‘taken into account’ in a deliberative process. 
Individual’s multi-criterial preferences cannot be treated as sociological or 
epidemiological characteristics, much as this would facilitate policymaking and clinical 
guideline formulation [1]. The well-intentioned attempts to incorporate the individual 
person’s preferences somehow and somewhere into the verbal reasoning process of the 
existing clinical model are, fortunately, doomed to fail. Fortunately, because the failures 
will lead to the paradigm change in which the clinician correctly remains a vital source 
of information for the decision maker, but no longer usurps, overtly or covertly, the 
decisional autonomy of the person. The autonomous person may, of course, choose to 
treat the clinician as agent, but the proportion of the population doing so is progressively 
diminishing, as rapidly increasing resort to Dr Google and other social network sources 
indicates. The Digital Health Manifesto of ‘e-patient Dave’ deBronkart and Bertalan 
Mesko foreshadows the future (http://medicalfuturist.com/digital-health). 
2. Realising the Vision 
Our work over the latest decade has focused on the development and application of a 
generic template for Personalised Decision Support Tools (PDSTs). In the person-
centred paradigm, these tools are best thought of as person decision support tools, rather 
than patient decision aids. They are not designed to help the professional make a better 
decision for the patient, so are not ‘clinician or clinical decision aids’. They can be used 
intermediatively, helping the professional – doctor, nurse, physiotherapist, nutritionist … 
make a better decision with the person, simultaneously ensuring that the person’s fully 
informed and preference-based consent has been obtained to any action following from 
the decision.  But, more important, they can be used apomediatively, helping the person 
make the best decision for themselves, including that on whether, and how, to engage 
with health services and professionals. Our PDSTs are primarily designed for 
apomediative use, but are easily used intermediatively.  
While recognizing the variety of existing definitions of ‘empowerment’ [2–5], in our 
conceptualisation of person-centred decision making [6,7] it is accepted:  
 that the individual person has multiple criteria (outcomes and process 
considerations, benefits and harms) that are important to them, and that these 
criteria have different importance weights in different individuals 
 that any clinical- or other provider-involving decision making process must 
explicitly elicit (or confirm) the person’s importance weights, for considerations 
that matter to them, at the point of decision; they cannot be replaced by the use 
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of average weights for considerations obtained from research e.g. patients’ 
tariffs from a Discrete Choice Experiment (DCE) 
 that these personalised preference inputs into the decision need to be integrated, 
in a transparent way, with the best available estimates of the personalised 
performance ratings for all possible options on their criteria, to produce a set of 
personalised option scores 
 that person-centred decision making defined in this way - since it involves 
personalised assessment of all the harms and benefits - can ensure that the 
person can give the legally-required informed and preference-based consent to 
any following action (including watchful waiting and no action).  
Given its cognitive and logistic demands, person-centred decision making requires 
an interactive, computer-based decision support tool, capable of integrating the 
individual’s preferences and producing an opinion in the form of a complete set of 
personalised option scores. This will not be a medical opinion and in our PDSTs, as in 
all MCDA tools, the output is a simple arithmetic calculation of the expected value of 
the importance weights and performance rates of each option.  This opinion is normally 
preliminary - a starting point - to a deliberative decision making phase and the tool 
includes an explicit disclaimer to the effect that it cannot reflect information unavailable 
to the person at the time of their engaging with it (e.g. a future test result, or a physical 
examination that may establish contraindication/s to particular option/s). This does, 
however, not undermine the dual, empowering and educational, functions of the 
apomediative decision support tool. 
No guideline or standard practice (local, regional, inter/national) can interfere with 
the ethical and legal obligation of providers to obtain the individual person’s informed 
and preference-based consent to all testing and treatment by personalised assessment of 
all the harms and benefits. Accordingly, the PDST should contain and analyse all 
possible options in the person’s present state, while issuing a warning that some of these 
options may not be available or reimbursable for this person (or possibly anyone) in their 
local setting. It is not ethically or legally acceptable for the provider in person-centered 
healthcare to suppress analysis of options that are not locally available in order ‘not to 
worry or upset our patients’ or to avoid having to explain their unavailability. Cost-
effectiveness considerations, ethically imperative in a resource-constrained service, may 
well impinge on option availability. However, the person – as citizen – must be explicitly 
informed that this is the basis of the unavailability. Cost-effectiveness must not influence 
decisions covertly, for example through threshold-based risk classifications. 
The challenge of introducing an alternative decision making paradigm into 
organisational settings characterised by deeply embedded incentive and training systems, 
is great. Personalised decision support tools needs to become part of the basic educational 
and practice infrastructure if stated goals, such as ‘patient first’ and ‘nothing about me 
without me’, are to be walked as well as talked.  
3. The Old Language of the New Paradigm  
Through MCDA-based decision support tools, users can achieve greater ability in the 
self-production of health via enhanced health decision literacy and clinicians can acquire 
decisional competence lacking in their formal training or practice. The education task is 
greatly facilitated by both parties using similar decision support tools as consumers, 
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when consulting comparison websites and magazines for products and services, such as 
domestic appliances or insurance provision. They simply have not regarded it is as the 
appropriate way to approach health decisions, because of the prevailing asymmetric 
agentist model. However, this asymmetry of information has largely disappeared, given 
the key information needed for decision making is identified as the performance rates of 
all available options on person-important criteria. These are now within the reach of 
anyone engaging with a PDST. Knowledge has been democratised. 
 
Figure 1. Screen captures from Annalisa representation of a Taenk.dk coffee maker example with 18 options 
(left) and from 17 option MyBoneHealth PDST (right) 
Our experience in delivering the MyBoneHealth PDST within the decision suite 
template of Annalisa, linked via an app to the electronic health journal of the Region of 
Southern Denmark, confirms that a basic introduction to MCDA through a non-health 
decision is essential for patients.  Most ‘get it’ once the structural similarity between 
deciding on a coffee maker and on an option for primary prevention of fragility fracture, 
clear from Figure 1, is established. (Access to the tool can be provided on request to 
mette.kjer.kaltoft@rsyd.dk). Some clinicians have seen this non-health preparation as a 
distraction in precious consultation time, possibly reflecting a wider scepticism about the 
technique from the perspective of the current paradigm. 
The educational task is actually tougher for clinicians, trained in a predominantly 
verbal qualitative intuitive reasoning mode of decision making (albeit with large amounts 
of quantitate inputs), whereas MCDA is a numerical quantitative analytical calculating 
approach (albeit with significant intuitive inputs). Apart from the familiarity with the 
technique, MCDA trumps in person-centred care, because it can incorporate the 
explicitly elicited quantitative preferences of persons over criteria important to them and 
synthesise them transparently with the best estimates available for the performance of all 
available options on those criteria. 
MCDA-based PDSTs provide the educational opportunity for the person to be 
introduced to: a prescriptive analytical approach to health decision making and its generic 
applicability to health self-production; the key distinction between evidence-based 
beliefs and value-based preferences and the need to synthesise them in decision making; 
the basic nature of measurement scales for probabilities and preferences; the issues of 
when and how, decisions should be evaluated.  
While disruptive of the status quo, MCDA-based PDSTs can reduce the 
professional’s legal worries, as well as burnout-producing attempts to keep ‘up to date’, 
a task now well beyond the ability of any human being. They will be more satisfyingly 
employed, delivering their valuable person-specific information support. In 
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intermediative use, the PDST will allow the clinician to modify performance rates on the 
basis of more individualized information. Just as important, the clinician will provide the 
human caring support which an online PDST cannot, and should not, be attempting. Its 
function is to produce an independent, detached, uncensored opinion. 
4. Conclusion 
Adopting the common and accessible language of MCDA in the clinical context means 
clinicians can communicate directly with the person, speaking the same common 
decisional language. So, the educational task of increasing generic health decision 
literacy is accomplished simultaneously with the use of the PDST to provide decision 
support purpose in a specific case. Whether the present prototypes are too ‘simplistic’ 
can only be answered by comparative empirical evaluations with standard care, using 
person-centred and person-reported primary outcomes. 
Acknowledgments 
We thank the contributors to MyBoneHealth development project along with the Danish Ministry of Health 
(SATS J.nr. 1-1010-116/27) and the Danish Consumer Council for use of the Taenk.dk examples. 
References 
[1] M. Kaltoft, J. Nielsen, G. Salkeld, J. Dowie, Preferences cannot be treated as epidemiological 
characteristics in person-centred care : a riposte, Eur. J. Pers. Centered Healthc. 4 (2016), 6–9. 
[2] A. Suárez Vázquez, A. B. Del Río Lanza, L. Suárez Álvarez, R. Vázquez Casielles, Empower Me? Yes, 
Please, But in My Way: Different Patterns of Experiencing Empowerment in Patients with Chronic 
Conditions, Health Commun. 32 (2017), 910–915. 
[3] K. E. Flynn, M. A. Smith, D. Vanness, A typology of preferences for participation in healthcare decision 
making, Soc. Sci. Med. 63 (2006), 1158–1169. 
[4] A. G. H. Thompson, The meaning of patient involvement and participation in health care consultations: A 
taxonomy, Soc. Sci. Med. 64 (2007), 1297–1310. 
[5] J. Dowie, The role of patients’ meta-preferences in the design and evaluation of decision support systems, 
Heal. Expect. 5 (2002), 16–27. 
[6] M. K. Kaltoft, J. Nielsen, Ø. Eiring, G. Salkeld, J. Dowie, Without a reconceptualisation of “evidence base” 
evidence-based person-centred healthcare is an oxymoron, Eur. J. Pers. Centered Healthc. 23 (2015), 
496–502. 
[7] M. K. Kaltoft, J. B. Nielsen, G. Salkeld, J. Dowie, Can a Discrete Choice Experiment contribute to person-
centred healthcare, Eur. J. Pers. Centered Healthc 23 (2015), 431-437. 
M.K. Kaltoft et al. / Dual Purpose, Dual Audience 261
